Weng, S.; Li, Q.; Zhang, T.; Lin, T.; He, Y.; Yang, G.; Wang, H.; Xu, Y.
Enhanced Glycosylation Caused by Overexpression of Rv1002c in a Recombinant BCG Promotes Immune Response and Protects against Mycobacterium tuberculosis Infection. Vaccines 2024, 12, 622.
https://doi.org/10.3390/vaccines12060622
AMA Style
Weng S, Li Q, Zhang T, Lin T, He Y, Yang G, Wang H, Xu Y.
Enhanced Glycosylation Caused by Overexpression of Rv1002c in a Recombinant BCG Promotes Immune Response and Protects against Mycobacterium tuberculosis Infection. Vaccines. 2024; 12(6):622.
https://doi.org/10.3390/vaccines12060622
Chicago/Turabian Style
Weng, Shufeng, Qingchun Li, Tianran Zhang, Taiyue Lin, Yumo He, Guang Yang, Honghai Wang, and Ying Xu.
2024. "Enhanced Glycosylation Caused by Overexpression of Rv1002c in a Recombinant BCG Promotes Immune Response and Protects against Mycobacterium tuberculosis Infection" Vaccines 12, no. 6: 622.
https://doi.org/10.3390/vaccines12060622
APA Style
Weng, S., Li, Q., Zhang, T., Lin, T., He, Y., Yang, G., Wang, H., & Xu, Y.
(2024). Enhanced Glycosylation Caused by Overexpression of Rv1002c in a Recombinant BCG Promotes Immune Response and Protects against Mycobacterium tuberculosis Infection. Vaccines, 12(6), 622.
https://doi.org/10.3390/vaccines12060622
